
NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for ...
Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy following radical hysterectomy and lymphadenectomy for patients with early-stage, intermediate-risk cervical …